Evidence map›Paper›PMID 35442771›Full record

Trial reportJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2022

Clinical Efficacy of an Eyedrop Containing Hyaluronic Acid and Ginkgo Biloba in the Management of Dry Eye Disease Induced by Cataract Surgery.

Paolo Fogagnolo, Dario Romano, Valentino De Ruvo, Pierfilippo Sabella, Luca Rossetti

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Diagnostic methods for managing dry eyes.World journal of methodology · 2025
    Article
  3. Plant-Based Care and Therapy in Ophthalmology.Antioxidants (Basel, Switzerland) · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Hyaluronic Acid in Nanopharmaceuticals: An Overview.Current issues in molecular biology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Paolo FogagnoloEye Clinic, ASST Santi Paolo e Carlo, Università degli Studi, Milan, Italy.ORCID 0000-0001-8183-5365
Dario RomanoEye Clinic, ASST Santi Paolo e Carlo, Università degli Studi, Milan, Italy.
Valentino De RuvoEye Clinic, ASST Santi Paolo e Carlo, Università degli Studi, Milan, Italy.
Pierfilippo SabellaEye Clinic, ASST Santi Paolo e Carlo, Università degli Studi, Milan, Italy.
Luca RossettiEye Clinic, ASST Santi Paolo e Carlo, Università degli Studi, Milan, Italy.
AOL (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CataractDry Eye SyndromesHyperemiaGinkgo bilobaHumansHyaluronic AcidOphthalmic SolutionsTearsTreatment OutcomeHyaluronic AcidOphthalmic Solutionscataract surgerydry eye diseaseginkgo bilobahyaluronic acid

Identifiers

PMID35442771
PMCPMC9125569
OpenAlexW4224285792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.